TickerFactsScreenerDevelopers

Ensysce Biosciences, Inc. (ENSC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $194.2K2021: $12.26M2022: $3.15M2023: $1.12M2024: $3.50M2025: $4.31M$4.31M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$4.31M+23.1%
2024$3.50M+211.7%
2023$1.12M-64.3%
2022$3.15M-74.3%
2021$12.26M+6215.1%
2020$194.2K—